Investor Presentaiton slide image

Investor Presentaiton

Genomics in health care With major advancements in genomics, we now have a much more detailed understanding of the link between our genes and our health. Genomics is the examination of all genes and how they interact with each other and the environment. Advances in genomic knowledge and technologies are providing new insights into the genetic causes of disease and is leading to the development of new treatments and management strategies. These applications extend from very rare conditions through to common, complex diseases such as diabetes and cancer. The integration of genomic knowledge and technologies in the healthcare setting enables: earlier and more precise disease detection and diagnosis earlier intervention new treatments tailored to the individual. The WA Genomics Strategy 2022-2032: Towards Precision Medicine and Precision Public Health, WA Genomics Strategy 2022-2032 Towards precision medicine and precision public health released in October 2022, aims to provide a statewide, strategic approach to the delivery of genomic health care in WA. The development of the strategy was guided by input from numerous stakeholders, including consumers, healthcare workers, researchers, and subject matter experts. The strategy's vision is to ensure the community benefit from the timely and appropriate translation of genomics by enabling precision medicine and precision public health. It aims to achieve this by coordinating and maximising stakeholder efforts and has identified 5 priorities areas, each with an accompanying goal for achievement. Implementation of the strategy is currently underway. In progress is the co-design of a Clinical Service Plan for Genetic Services of Western Australia. Also, access to ultra-rapid whole genome sequencing is being facilitated for eligible critically ill babies and children in intensive care units, and 2 rare diseases (spinal muscular atrophy and severe combined immunodeficiency) have been added to the state's Newborn Bloodspot Screening Program. < 37 > Contents • About us Significant issues Report on operations Agency performance Operational disclosures Key performance indicators • Financial disclosures and compliance • Appendix
View entire presentation